Data Snapshot: Sep 06, 2026
$100K+

Aug-2026

Sales

Decline

Trend

6-Month

65

Product Count

SKUs

$17.75

Avg Price

-19%

YoY Sales Change

1.1%

YoY Price Change

Mr. Moxey's, a trailblazer in the therapeutic cannabis field, stands out for its innovative combination of traditional herbs and modern CBD research to naturally enhance well-being. As the creator of the country's leading low-dose edible and widely acclaimed CBD infused products, the brand has successfully reshaped expectations for cannabis edibles. With a focus on integrating specific herbal blends with cannabis or hemp to affect mood states, and strategic partnerships facilitating product expansion, this adults-only brand is rapidly gaining national recognition.
Mr. Moxey's

Where to Buy

Mr. Moxey's is stocked at 443 licensed dispensaries across Washington, Oregon, and 3 other states, 171 of them in Washington, with the deepest coverage in Seattle, Everett, Tacoma, Olympia, and Vancouver. Search by ZIP code or city below to find the closest one.

https://headsetstorage.blob.core.windows.net/brand-stores/334.json?v=20260905
Mr. Moxey's Sales

Market Insights Snapshot

Mr. Moxey's Historical Sales by Category

In August 2026, Mr. Moxey's revenue was concentrated in Edible at 99.78% share while Capsules accounted for 0.22%, indicating a highly concentrated mix that narrowed month over month as Edible fell 10.16% MoM and 19.09% YoY. Capsules moved in the opposite direction with 144.91% MoM growth and 7.22% YoY growth, but the tiny base left overall mix largely unchanged, while the brand’s average price rose 1.11% YoY alongside a 19.04% YoY sales decline. With Edible ranked 14 in Colorado and WA as the top state, the pattern implies reliance on a single category and state footprint that amplifies volatility when Edible decelerates.

The divergence between a 10.16% MoM drop in Edible and a 144.91% MoM jump in Capsules implies early-stage experimentation rather than a material pivot, since Edible still holds 99.78% mix and drives the 19.04% YoY sales contraction. A 1.11% YoY price lift alongside a 19.09% YoY decline in Edible suggests elasticity pressure or mix down within Edible, and the 7.22% YoY growth in Capsules is insufficient to offset that given its 0.22% share; combined with a 14 rank in Colorado, this positioning implies that stabilizing Edible velocity is the primary lever while selectively scaling Capsules could hedge category risk without moving price sensitivity further.

Aug-2026 Rank
Edible
14
26
68
17
16
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Edible
99.8%
$17.76
-19.1%
-10.2%
Capsules
0.2%
$16.09
+7.2%
+144.9%
Mr. Moxey's

Competitive Landscape

Mr. Moxey's sits at rank #16 in Washington Edible for August 2026, down 4 positions from #12 year over year and also 4 places below its three-month mark of #12, despite a peak at #11 in January 2026. In contrast, Wyld held #1 year over year and remains #1 with sales up 5.1%, while Green Revolution stayed at #2 with sales down 7.0%, indicating that Mr. Moxey's relative slippage is less about a single accelerating rival and more about losing share amid a stable top tier. The pattern implies that the brand’s four-rank retreat from #12 to #16, alongside a flat competitive leaderboard at #1 and #2, points to drift out of the consideration set rather than displacement by a single surging competitor.

Mr. Moxey's market ranking for WA Edible

Mr. Moxey's

Notable Products

The steepest decline came from Energizing Peppermint Mints 20-Pack (100mg), which fell 43.1% month over month and slid to rank 3, while CBD/THC 1:1 Balance Peppermint Mints 20-Pack (100mg CBD, 100mg THC) dropped 23.1% to rank 5. In contrast, CBN/CBD/THC 1:1:1 Dream Lavender Mints 20-Pack (100mg CBN, 100mg CBD, 100mg THC) jumped 22.8% to hold rank 2 as CBG/CBD/THC 1:1:1 Relief Lemon Ginger Mints 20-Pack (100mg CBG, 100mg CBD, 100mg THC) inched up 2.0% at rank 1. With all top ten SKUs in Edible mints and two cannabinoid-blend 1:1:1 formats occupying ranks 1–2, the mix signals a pivot toward multi-cannabinoid functionals anchoring the lineup over legacy single-flavor peppermint variants.

Product
Category
Apr-2026
May-2026
Jun-2026
Jul-2026
Aug-2026
MoM %
CBG/CBD/THC 1:1:1 Relief Lemon Ginger Mints 20-Pack (100mg CBG, 100mg CBD, 100mg THC)
Edible
1
1
2
1
1
+2.0%
CBN/CBD/THC 1:1:1 Dream Lavender Mints 20-Pack (100mg CBN, 100mg CBD, 100mg THC)
Edible
5
5
4
3
2
+22.8%
Energizing Peppermint Mints 20-Pack (100mg)
Edible
4
2
1
2
3
-43.1%
CBG/CBC/THC 1:1:1 Energize Peppermint Mints 20-Pack (100mg CBG, 100mg CBC, 100mg THC)
Edible
>10
>10
8
5
4
+33.8%
CBD/THC 1:1 Balance Peppermint Mints 20-Pack (100mg CBD, 100mg THC)
Edible
2
3
3
4
5
-23.1%
CBD/THC 3:1 Relax Vanilla Peppermints 20-Pack (300mg CBD, 100mg THC)
Edible
>10
>10
>10
10
6
+13.8%
Relax Cinnamon Mints 20-Pack (100mg)
Edible
>10
10
>10
8
7
-9.6%
CBC/THC 1:1 Energize Peppermint Mints 20-Pack (100mg CBC, 100mg THC)
Edible
3
4
5
9
8
-12.5%
CBG/THC 3:1 Balance Peppermint Mints 20-Pack (300mg CBG, 100mg THC)
Edible
>10
>10
>10
>10
9
CBD/THC 40:1 Zen Peppermint Mints 20-Pack (800mg CBD, 20mg THC)
Edible
6
6
9
>10
10
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market